Table 5. Survival probability of lung cancer incident cases by survival time, sex, age group and year of diagnosis.
2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | |
---|---|---|---|---|---|---|---|---|---|---|---|
5-year survival | |||||||||||
Total (+) | 19.0 | 18.6 | 18.9 | 19.7 | 18.8 | 19.8 | 19.7 | – | – | – | – |
Sex | |||||||||||
Men (+) | 14.9 | 15.6 | 15.2 | 16.9 | 15.4 | 16.7 | 17.9 | – | – | – | – |
Women (−) | 24.2 | 22.5 | 23.4 | 23.2 | 22.9 | 23.4 | 21.9 | – | – | – | – |
Age group | |||||||||||
18–35 (−) | 71.4 | 75.0 | 88.9 | 62.5 | 52.4 | 68.8 | 56.2 | – | – | – | – |
35–50 (+) | 28.3 | 27.7 | 29.6 | 28.9 | 30.9 | 32.8 | 38.6 | – | – | – | – |
50–65 | 22.0 | 22.4 | 22.9 | 24.6 | 22.4 | 24.4 | 22.2 | – | – | – | – |
65–80 (+) | 18.5 | 18.0 | 17.9 | 19.2 | 18.5 | 18.6 | 20.1 | – | – | – | – |
80+ (−) | 8.3 | 6.6 | 8.5 | 7.0 | 7.2 | 8.4 | 6.6 | – | – | – | – |
3-year survival | |||||||||||
Total (+) | 24.4 | 24.7 | 25.3 | 26.1 | 25.4 | 26.7 | 26.2 | 26.9 | 27.8 | – | – |
Sex | |||||||||||
Men (+) | 20.5 | 21.2 | 21.1 | 22.8 | 22.1 | 23.7 | 24.0 | 23.5 | 23.9 | – | – |
Women (+) | 29.3 | 29.2 | 30.5 | 30.2 | 29.5 | 30.1 | 28.9 | 30.8 | 32.1 | – | – |
Age group | |||||||||||
18–35 | 71.4 | 75.0 | 88.9 | 62.5 | 57.1 | 68.8 | 56.2 | 80.0 | 66.7 | – | – |
5-50 (+) | 33.2 | 33.2 | 34.9 | 34.0 | 37.5 | 38.2 | 41.7 | 45.0 | 47.5 | – | – |
50–65 | 27.2 | 28.5 | 29.6 | 30.2 | 28.3 | 31.0 | 28.9 | 29.3 | 31.3 | – | – |
65–80 (+) | 24.3 | 24.7 | 24.4 | 26.1 | 25.7 | 26.0 | 26.9 | 27.5 | 27.5 | – | – |
80+ | 12.8 | 10.8 | 14.8 | 14.1 | 13.8 | 15.2 | 12.7 | 13.9 | 13.9 | – | – |
1-year survival | |||||||||||
Total (+) | 48.5 | 48.6 | 48.8 | 49.9 | 49.3 | 50.5 | 49.5 | 50.7 | 51.4 | 50.6 | 51.2 |
Sex | |||||||||||
Men | 45.0 | 45.2 | 45.0 | 45.7 | 46.0 | 47.5 | 47.1 | 47.6 | 48.1 | 46.1 | 48.1 |
Women | 53.0 | 52.7 | 53.6 | 55.1 | 53.4 | 53.9 | 52.3 | 54.3 | 55.1 | 55.5 | 54.4 |
Age group | |||||||||||
18–35 | 92.9 | 83.3 | 88.9 | 93.8 | 85.7 | 75.0 | 75.0 | 80.0 | 83.3 | 90.0 | 72.7 |
35–50 | 60.6 | 60.2 | 54.5 | 59.5 | 64.7 | 62.2 | 62.6 | 69.0 | 67.7 | 59.1 | 69.9 |
50–65 (+) | 51.8 | 53.5 | 55.0 | 53.9 | 55.2 | 55.9 | 55.1 | 55.0 | 56.1 | 57.0 | 56.6 |
65–80 (+) | 49.4 | 49.2 | 48.1 | 50.6 | 49.2 | 50.5 | 49.5 | 50.8 | 51.4 | 51.0 | 51.0 |
80+ (+) | 31.1 | 28.6 | 35.2 | 34.8 | 31.5 | 33.5 | 32.5 | 35.1 | 35.0 | 34.2 | 36.1 |
6-month survival | |||||||||||
Total | 67.5 | 67.0 | 67.3 | 68.3 | 67.2 | 68.1 | 67.4 | 68.1 | 68.1 | 68.4 | 67.4 |
Sex | |||||||||||
Men | 65.7 | 64.5 | 64.5 | 65.2 | 65.1 | 65.7 | 66.2 | 66.8 | 65.7 | 64.7 | 65.2 |
Women | 69.9 | 70.3 | 70.8 | 72.1 | 69.8 | 70.8 | 68.8 | 69.5 | 70.8 | 72.4 | 69.7 |
Age group | |||||||||||
18–35 | 100.0 | 100.0 | 88.9 | 93.8 | 95.2 | 93.8 | 87.5 | 100.0 | 88.9 | 100.0 | 90.9 |
35–50 | 77.5 | 78.9 | 76.4 | 80.8 | 79.3 | 80.7 | 80.7 | 83.7 | 82.5 | 79.0 | 82.1 |
50–65 (+) | 73.0 | 72.9 | 72.4 | 73.9 | 73.3 | 74.1 | 73.6 | 74.2 | 73.6 | 76.1 | 72.6 |
65–80 | 67.5 | 66.9 | 67.8 | 67.9 | 67.6 | 67.9 | 67.2 | 67.7 | 68.2 | 68.2 | 67.4 |
80+ | 49.3 | 47.4 | 51.1 | 53.2 | 48.7 | 50.3 | 50.3 | 51.1 | 49.9 | 50.9 | 52.8 |
3-month survival | |||||||||||
Total | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.82 | 0.81 | 0.81 |
Sex | |||||||||||
Men | 0.80 | 0.79 | 0.79 | 0.79 | 0.80 | 0.80 | 0.80 | 0.80 | 0.81 | 0.79 | 0.80 |
Women | 0.82 | 0.84 | 0.84 | 0.84 | 0.82 | 0.83 | 0.82 | 0.82 | 0.84 | 0.84 | 0.82 |
Age group | |||||||||||
18–35 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.94 | 1.00 | 1.00 | 0.94 | 1.00 | 1.00 |
35–50 | 0.87 | 0.89 | 0.88 | 0.91 | 0.91 | 0.92 | 0.89 | 0.93 | 0.92 | 0.89 | 0.92 |
50–65 (+) | 0.85 | 0.86 | 0.84 | 0.86 | 0.86 | 0.85 | 0.85 | 0.85 | 0.87 | 0.87 | 0.85 |
65–80 | 0.82 | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.82 | 0.81 | 0.80 |
80+ (+) | 0.65 | 0.67 | 0.71 | 0.70 | 0.67 | 0.70 | 0.69 | 0.70 | 0.70 | 0.68 | 0.72 |
Note: If the three year average is always higher (lower) than the three year average of the period immediately before, the trend is labeled as increased (decreasing). An increasing trend in survival is denoted by (+), a decreasing trend by (−).